Annual report pursuant to Section 13 and 15(d)

STOCKHOLDERS EQUITY (DEFICIT) (Details Narrative)

v3.24.0.1
STOCKHOLDERS EQUITY (DEFICIT) (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Jun. 12, 2023
Oct. 26, 2023
Dec. 19, 2022
Dec. 16, 2022
Aug. 29, 2022
Jul. 28, 2022
Feb. 22, 2022
Nov. 29, 2019
Dec. 31, 2023
Dec. 31, 2022
Jan. 01, 2023
Expenses for options and warrants granted to employees                 $ 870,000 $ 2,700,000  
Epenses for R & D obligation                 230,000 500,000  
Expenses was attributed to G & A                 $ 640,000 $ 2,200,000  
Common stock and treasury shares, Description   1-for-6 basis and (ii) decrease the number of total authorized shares of common stock of the Company from 150,000,000 to 25,000,000 shares                  
Common stock shares issuance                 437,692    
Reverse stock split of common stock   As of the Effective Time, every 6 shares of issued and outstanding common stock were converted into one share of common stock                  
Agents fee             $ 1,155,722   $ 337,682    
Common stock, par value                 $ 0.001 $ 0.001  
Proceed from stock issuances                 $ 485,000    
Unpaid directors' fees                   $ 172,670  
Remining shares available for issuance                 91,559    
Expected Dividends                 0.00% 0.00%  
Volatility range                 112.28%    
Common stock value                 $ 2,383 $ 1,570  
On July 5, 2023                      
Purchase price                 $ 16.02    
Agents fee                 $ 365,000    
Common stock, par value                 $ 0.001    
Exercise price                 $ 0.0006    
Pre-funded warrants                 78,021    
Gross proceeds of stock                 $ 4,000,000    
Offering price                 $ 16.0194    
Proceed from stock issuances                 $ 171,666    
Common stock share issued, restricted                 78,021    
Private Investors [Member]                      
Common stock shares issuance                 563,016    
Investor Private Placement Member                      
Proceed from stock issuances                 $ 640,000    
2019 Incentive Plan [Member]                      
Incentive plan, description               Equity Incentive Plan, the Company maintained a 2019 Omnibus Long-Term Incentive Plan (the “2019 Plan”). Following the approval by the shareholders of the 2021 Equity Incentive Plan, no additional awards have been or will be made under the 2019 Plan. As of December 31, 2023, 130,203 stock options had been issued under the 2019 Plan with terms between 5 years and 10 years, of which 60,414 remained outstanding      
Private Placement Securities [Member]                      
Shares available for issuance, shares                 249,688    
Exercise price                 $ 16.80    
Offering price                 $ 16.80    
Common stock share issued, restricted                 249,688    
Securities Purchase Agreement [Member]                      
Common stock shares issuance                 78,021    
Received from common stock shares issued                 $ 47    
2021 Incentive Plan [Member]                      
Stock options, issued                 232,101   166,666
Black Scholes Pricing Model [Member]                      
Grants shares 10,878   23,240                
Grants shares, amount $ 3,626     $ 4,244              
Proceed from related party $ 50,000   $ 300,000 $ 10,000   $ 50,000          
Average weighted remaining contructual life in years 5 years 3 months 21 days   5 years 5 years   5 years 3 months 21 days          
Expected Dividends 0.00%   0.00% 0.00%   0.00%          
Discount rates 3.88%   3.70% 3.61%   2.69%          
Volatility range 112.25%   116.47% 116.42%   120.99%          
Common stock value $ 50,000   $ 300,000 $ 10,000 $ 173,000 $ 50,000          
Black Scholes Pricing Model [Member] | 2021 [Member]                      
Common stock purchased, related party       31,836 28,831   28,747        
Average weighted remaining contructual life in years       5 years 5 years 9 months   5 years 9 months        
Expected Dividends       0.00% 0.00%   0.00%        
Discount rates       3.60% 3.25%   1.88%        
Volatility range       116.41% 121.19%   130.18%